TrialLancet (London, England)2020

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

Kenneth H Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.